R1 RCM Inc (RCM)
14.31
0.00 (0.00%)
USD |
NASDAQ |
Nov 20, 16:00
R1 RCM Enterprise Value: 8.087B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 20, 2024 | 8.087B |
November 19, 2024 | 8.087B |
November 18, 2024 | 8.087B |
November 15, 2024 | 8.082B |
November 14, 2024 | 8.082B |
November 13, 2024 | 8.082B |
November 12, 2024 | 8.078B |
November 11, 2024 | 8.078B |
November 08, 2024 | 8.074B |
November 07, 2024 | 8.074B |
November 06, 2024 | 8.070B |
November 05, 2024 | 8.070B |
November 04, 2024 | 8.074B |
November 01, 2024 | 8.066B |
October 31, 2024 | 8.062B |
October 30, 2024 | 8.062B |
October 29, 2024 | 8.057B |
October 28, 2024 | 8.057B |
October 25, 2024 | 8.057B |
October 24, 2024 | 8.053B |
October 23, 2024 | 8.053B |
October 22, 2024 | 8.051B |
October 21, 2024 | 8.053B |
October 18, 2024 | 8.057B |
October 17, 2024 | 8.049B |
Date | Value |
---|---|
October 16, 2024 | 8.036B |
October 15, 2024 | 8.049B |
October 14, 2024 | 8.036B |
October 11, 2024 | 8.040B |
October 10, 2024 | 8.045B |
October 09, 2024 | 8.049B |
October 08, 2024 | 8.040B |
October 07, 2024 | 8.036B |
October 04, 2024 | 8.032B |
October 03, 2024 | 8.028B |
October 02, 2024 | 8.032B |
October 01, 2024 | 8.028B |
September 30, 2024 | 8.024B |
September 27, 2024 | 8.082B |
September 26, 2024 | 8.082B |
September 25, 2024 | 8.074B |
September 24, 2024 | 8.074B |
September 23, 2024 | 8.066B |
September 20, 2024 | 8.078B |
September 19, 2024 | 8.074B |
September 18, 2024 | 8.087B |
September 17, 2024 | 8.078B |
September 16, 2024 | 8.087B |
September 13, 2024 | 8.061B |
September 12, 2024 | 8.061B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.136B
Minimum
Mar 18 2020
12.67B
Maximum
Aug 08 2022
6.292B
Average
7.048B
Median
Enterprise Value Benchmarks
Panamera Holdings Corp | 90.89M |
TruBridge Inc | 406.63M |
PetMed Express Inc | 43.84M |
LENZ Therapeutics Inc | 726.72M |
Oruka Therapeutics Inc | 309.53M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -19.90M |
Revenue (Quarterly) | 656.80M |
Total Expenses (Quarterly) | 607.80M |
EPS Diluted (Quarterly) | -0.05 |
Gross Profit Margin (Quarterly) | 16.95% |
Profit Margin (Quarterly) | -3.03% |
Earnings Yield | -1.01% |
Operating Earnings Yield | 3.78% |
Normalized Earnings Yield | -0.1504 |